April 12, 2017 — Client Outlook recently announced the latest release of its flagship diagnostic and clinical image viewing platform, eUnity. The release of eUnity 6 coupled with Client Outlook’s recent U.S.

Theraclion announced results of a study evaluating the long-term assessment of breast fibroadenoma (benign tumor) volume reduction following treatment with the company’s Echopulse, a non-invasive treatment employing ultrasound-guided high-intensity focused ultrasound. 

In contrast to other U.S. racial/ethnic groups, Asian Americans have experienced steadily increasing breast cancer rates over the past 15 years.

April 12, 2017 — JPI Healthcare has completed the installation of a CareRay dual panel X-Vue digital radiography (DR) system at Ortho Northwest in Oregon. The sale and installation was facilitated by Pacific Northwest X-Ray of Gresham, Ore., a JPI Healthcare dealer.

Ortho Northwest provides patients throughout the Tigard area of northwest Oregon with the most advanced, accessible, and comprehensive orthopedic care under one roof, according to the company. 

April 12, 2017 — Providers can now offer enhanced care and safe imaging to patients with a compact and economical solution thanks to Toshiba Medical’s Aquilion Lightning 80 computed tomography (CT) system. The 80-detector row (160-slice*) system is designed for full body imaging and routine volumetric scanning with the premium CT technology found on high-end systems so that providers can deliver a better patient experience.            

Parascript LLC announced a new partnership with Volpara Solutions, creator of Volpara Density automated breast density assessment software. Independent research has associated an increased risk of cancer for patients with high breast density, which can also make cancer harder to detect on conventional mammograms. Together, Parascript AccuDetect CAD (computer-aided detection) and VolparaDensity provide complementary early cancer detection solutions.

IBA Molecular announced that it has merged with previous acquisition Mallinckrodt Nuclear Medicine LLC to form the new company Curium.

The U.S. Food and Drug Administration (FDA) has cleared the Somatom go. computed tomography (CT) platform from Siemens Healthineers, designed for highly diverse sets of user needs.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now